{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:40:42Z","timestamp":1761666042640,"version":"build-2065373602"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"23","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Choline kinase (CK) is a homodimeric enzyme that catalyses the transfer of the ATP &amp;#947;-phosphate to choline,\ngenerating phosphocholine and ADP in the presence of magnesium. Several isoforms of CK are present in humans but\nonly the HsCK&amp;#945; has been associated with cancer and validated as a drug target to treat this disease. As a consequence a\nlarge number of compounds based on Hemicholinium (HC-3) have been described. Two compounds, previously reported\nto inhibit the human enzyme, have recently been shown to inhibit P. falciparum CK (PfCK) and therefore their potential\napplications might be anticipated to other pathogens. Herein, using molecular dynamic simulations, we have firstly observed\nthat the ATP and the choline binding site of different CK in pathogens and human are conserved, suggesting that\nprevious compounds inhibiting the human enzyme may also interact with CKs from different pathogens. We have substantiated\nsuch observation with experimental assays showing that HsCK&amp;#945;1, PfCK and CpCK bind to two compounds\nwith distinct structural features in the low &amp;#956;M range. Collectively, these results uncover similarities among the choline\nkinase binding site from different pathogenic species and the human enzyme, highlighting the feasibility of designing\nnovel inhibitors based on the choline binding pocket.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1568026614666141216093337","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T06:23:30Z","timestamp":1420698210000},"page":"2684-2693","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Choline Kinase Active Site Provides Features for Designing Versatile Inhibitors"],"prefix":"10.2174","volume":"14","author":[{"given":"L.","family":"Serran-Aguilera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.C.","family":"Lopez-Cara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rios-Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Entrena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Macchiarulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hurtado-Guerrero","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Organic Chemistry, Faculty of Pharmacy, University of Granada, Campus Cartuja, Granada 18071, Spain.,Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026614666141216093337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/126942\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1568026614666141216093337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:33:27Z","timestamp":1761665607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/126942\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":0,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568026614666141216093337","relation":{},"ISSN":["1568-0266"],"issn-type":[{"type":"print","value":"1568-0266"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2013-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-01-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}